The global market size of infertility drugs is expected to reach USD 4.8 billion by 2028, increasing with a market growth of 6.2% CAGR during the forecast period.
Market growth factors
Factors that increase cases of infertility in men and women
The rising prevalence of infertility or the difficulty of carrying a baby to term around the world is what fuels the infertility drug market. Infertility can be caused by a number of diseases that affect both men and women, including diabetes, cystic fibrosis, testicular failure, hormonal imbalances, menopausal disorders, urinary tract infections, pelvic inflammatory disease (PID), endometriosis, ovarian cysts, among others. others . Smoking, using anabolic steroids, stress, obesity and other poor lifestyle choices are to blame for the increase in these problems, which also contributes to the need for infertility medication.
Increasing research and development for better treatment
Due to increasing research studies and development of more efficient treatments to induce conception and deliver live babies, the market for infertility drugs is expected to expand significantly. For example, a group of researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) found in 2014 that women treated with letrozole have higher rates of ovulation and live births than the women treated with the standard medication, Clomiphene.
End User Outlook
Based on the end user, the infertility drug market is divided into men and women. The female segment led the market with the highest market revenue share in 2021. This dominance could be related to the wide accessibility of female infertility drugs. In the United States, 11% of women and 9% of men of reproductive age are infertile, according to the US Department of Health and Human Services.
Distribution Channel Perspectives
Based on the distribution channel, the infertility drug market is divided into hospital pharmacy, specialty and retail pharmacy, and online pharmacy. Online Pharmacy generated significant revenue share during 2021 in the market. The emergence of online clinical chains, which provide patients with scheduled medication deliveries and promote patient discretion due to the social stigma associated with the disease, can be credited with the rise of the segment.
Drug Class Perspective
Based on drug class, the infertility drug market is classified into gonadotropins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), dopamine agonists, and others. The gonadotropins segment accounted for the largest share of market revenue in 2021. This can be attributed to the high cost of products and the effect of greater effectiveness on increased consumption. Gonal-F, Follitismo, Menopur and Bravelle gonadotropins are some of the most frequently prescribed for the treatment of infertility in patients.
By end user
By Distribution Channel
Specialty and retail pharmacy
By drug class
Selective Estrogen Receptor Modulators (SERMs)
Main market players
List of companies profiled in the report:
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Ferring Holdings SA
Organon & Co.
Pharmaceutical Humanity Ltd.
Main topics covered:
Chapter 1. Market Scope and Methodology
Chapter 2. Market overview
Chapter 3. Global Infertility Drugs Market by End User
Chapter 4. Global Infertility Drugs Market by Distribution Channel
Chapter 5. Global Infertility Drug Market by Drug Class
Chapter 6. Global Infertility Drugs Market by Region
Chapter 7. Company Profiles
For more information on this report, please visit https://www.researchandmarkets.com/r/j24u5p
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key sectors, top companies, new products and the latest trends.